Published in Support Care Cancer on April 29, 2005
Neoplastic fever: all who shiver are not infected. Support Care Cancer (2005) 0.75
Pancreatic carcinoma masked as fever of unknown origin: A case report and comprehensive review of literature. Medicine (Baltimore) (2016) 0.75
Fever of unknown origin: a clinical mask of malignant peritoneal mesothelioma. Contemp Oncol (Pozn) (2013) 0.75
Neoplastic fever in patients with bone and soft tissue sarcoma. Mol Clin Oncol (2016) 0.75
Systemic inflammatory response syndrome in a patient diagnosed with high grade inflammatory triple negative breast cancer: a case report of a potentially rare paraneoplastic syndrome. Exp Hematol Oncol (2016) 0.75
Procalcitonin as diagnostic marker of infection in solid tumors patients with fever. Sci Rep (2016) 0.75
Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study. PLoS One (2017) 0.75
Expression of CD11b/CD18 adhesion molecules on circulating phagocytes-a novel aid to diagnose infection in patients with cancer. Support Care Cancer (2008) 0.75
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet (2004) 9.88
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis (2002) 7.81
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med (1991) 6.33
Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid. Lancet (1968) 5.30
Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med (1976) 5.16
From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med (2003) 2.84
Fever of unknown origin. Lancet (1997) 2.77
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res (1992) 2.64
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol (2003) 2.63
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Neoplastic fever. Palliat Med (1996) 2.05
Fever of undetermined origin. N Engl J Med (1973) 1.77
The role of cytokines in cancer-related fatigue. Cancer (2001) 1.75
Nitroblue tetrazolium dye test as an aid in the differential diagnosis of febrile disorders. J Pediatr (1971) 1.71
Bone marrow necrosis. Cancer (2000) 1.70
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer (1997) 1.70
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol (2003) 1.66
Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol (1986) 1.50
Pathogenesis of fever in man. N Engl J Med (1978) 1.43
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol (1995) 1.30
The significance of fever in neoplastic disease. Ann Intern Med (1961) 1.13
The biosynthesis of prostaglandins by brain tissue in vitro. Adv Prostaglandin Thromboxane Res (1976) 1.08
Pyrexia in renal carcinoma. Lancet (1970) 1.06
Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasma. Am J Hematol (1988) 1.04
Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med (1986) 1.03
Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders. Med Oncol (2001) 1.01
Pyrogen in the urine of febrile patients with Hodgkin's disease. Nature (1967) 0.93
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS. Cancer Res (1999) 0.91
Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med (2000) 0.91
A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever. J Intern Med (1990) 0.88
Generalized perturbations in host physiology caused by localized tumors. Tumors and fever. Ann N Y Acad Sci (1974) 0.87
C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer (2001) 0.86
Neoplastic fever responds to the treatment of an adequate dose of naproxen. J Clin Oncol (1985) 0.85
Nitroblue tetrazolium test in Hodgkin disease and other malignant lymphomas. Arch Intern Med (1974) 0.85
Suppression of prolonged fever during treatment of pulmonary tuberculosis: importance of using twice versus single daily dose of prednisolone. Postgrad Med J (1983) 0.83
Bleomycin-induced fatal hyperpyrexia. Am J Med (1983) 0.83
Mechanism of action of pyrogenic and antipyretic steroids in vitro. Ciba Found Symp (1971) 0.82
Neoplastic fever. A proposal for diagnosis. Arch Intern Med (1989) 0.82
Cyclo-oxygenase II inhibitors in the treatment of neoplastic fever. Support Care Cancer (2003) 0.81
Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses. Am J Med (2003) 0.81
Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med (1984) 0.80
Fever. Semin Oncol (1997) 0.79
The effect of naproxen on fever in patients with advanced gynecologic malignancies. Gynecol Oncol (1995) 0.78
Fever of unknown origin. Infect Dis Clin North Am (1996) 0.77
Endogenous pyrogen production by Hodgkin's disease and human histiocytic lymphoma cell lines in vitro. J Clin Invest (1980) 0.77
Antipyretic effect of naproxen and corticosteroids on neoplastic fever. J Pain Symptom Manage (1988) 0.77
Antipyretic effect of indomethacin in patients with malignancy. Cancer (1968) 0.76
Oral antipyretic therapy evaluation of the propionic acid derivatives ibuprofen, ketoprofen, fenoprofen and naproxen. Padiatr Padol (1980) 0.75
How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test. Heart Lung (1987) 0.75
Streptozocin-induced eosinophilia and fever: a case report. Cancer Treat Rep (1982) 0.75
Comparative effects of naproxen and aspirin on fever in children. J Pediatr (1979) 0.75
Dantrolene and potentially fatal hyperthermia secondary to L-asparaginase. Cancer Treat Rep (1983) 0.75
Effectiveness of adrenal corticosteroids in the management of severe bacterial infections. Rev Eur Etud Clin Biol (1971) 0.75
Vincristine-induced fever in children with leukemia and lymphoma. Cancer (1988) 0.75
Pyrexia after cisplatin. Lancet (1980) 0.75
Postoperative thrombotic thrombocytopenic purpura after open heart operations. Ann Thorac Surg (2010) 1.54
Acute thrombotic thrombocytopenic purpura following orthopedic surgery. J Clin Apher (2002) 0.83
A case report of total abdominal hysterectomy resulting in acute thrombotic thrombocytopenic purpura with pancreatitis and hepatitis: complete resolution with plasma exchange therapy. Ther Apher Dial (2003) 0.82
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab. Anticancer Drugs (2005) 0.80
Why do we still use the term FUO? Arch Intern Med (2003) 0.75
Redefining the syndromes of thrombotic microangiopathy. Ther Apher Dial (2004) 0.75